Verona Pharma plc (VRP.L) (LON:VRP) Stock Price Passes Above 200-Day Moving Average – Here’s Why

Verona Pharma plc (VRP.L) (LON:VRP) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 55 ($0.71) and traded as high as GBX 56 ($0.73). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.71), with a volume of 70,791 shares trading hands.

Verona Pharma plc (VRP.L) Stock Performance

The firm has a fifty day moving average price of GBX 55 and a 200 day moving average price of GBX 55. The firm has a market capitalization of £228.00 million and a PE ratio of -1.68. The company has a debt-to-equity ratio of 6.85, a current ratio of 2.99 and a quick ratio of 2.47.

About Verona Pharma plc (VRP.L)

Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.